Mortality increased in association with SARS-CoV-2 U.K. variant

Mortality increased in association with SARS-CoV-2 U.K. variant

(HealthDay)—The risk for mortality is increased in association with infection with a new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) designated a variant of concern (VOC-202012/1) in December 2020, according to a study published online March 10 in The BMJ.

Robert Challen, Ph.D., from the University of Exeter in the United Kingdom, and colleagues conducted a involving 54,906 matched pairs of participants who tested positive for SARS-CoV-2 in community-based COVID-19 testing centers between Oct. 1, 2020, and Jan. 29, 2021. Participants differed only on detectability of the spike protein gene using the TaqPath assay (a proxy measure of VOC-202012/1 infection).

The researchers found that for patients who tested positive for COVID-19 in the community, the mortality hazard ratio associated with infection with VOC-202012/1 compared with with previously circulating variants was 1.64. This represented an increase in deaths from 2.5 to 4.1 per 1,000 detected cases in this relatively low-risk group.

"In the community, death from COVID-19 is still a rare event, but the B.1.1.7 variant raises the risk," Challen said in a statement. "Coupled with its ability to spread rapidly this makes B.1.1.7 a threat that should be taken seriously."

Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak

More information: Abstract/Full Text

Copyright © 2020 HealthDay. All rights reserved.

Citation: Mortality increased in association with SARS-CoV-2 U.K. variant (2021, March 16) retrieved 13 May 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments